PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration

BACKGROUND: Continuous hemodiafiltration (CHDF) is used as renal replacement therapy for critically ill patients with renal failure, and to treat hypercytokinemia. Since CHDF also clears therapeutic agents, drug pharmacokinetics (PK) should be dependent upon CHDF conditions. Although the antibiotic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharm Health Care Sci
Main Authors: Akashita, Gaku, Hosaka, Yuto, Noda, Toru, Isoda, Kazuya, Shimada, Tsutomu, Sawamoto, Kazuki, Miyamoto, Ken-ichi, Taniguchi, Takumi, Sai, Yoshimichi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728804/
https://ncbi.nlm.nih.gov/pubmed/26819742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-015-0031-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados